Navigation Links
Boston Scientific to Participate in Cowen Health Care Conference
Date:3/10/2009

NATICK, Mass., March 10 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the upcoming Cowen and Company 29th Annual Health Care Conference.

Jim Tobin, Chief Executive Officer, will make a 35-minute presentation on Tuesday, March 17th, beginning at approximately 3:55 p.m. E.T. Following the presentation, Sam Leno, Executive Vice President and Chief Financial Officer will join Mr. Tobin in a question and answer session.

A live webcast of Mr. Tobin's remarks will be available to all interested parties at Boston Scientific's website at www.bostonscientific.com. Please visit the website for details on how to access the webcast. To ensure a timely connection to the webcast, it is recommended that users register at least 15 minutes before the webcast begins.

This webcast is being hosted by Cowen. The replay will be archived and available in the Investor Relations site at www.bostonscientific.com by 6:30 p.m. E.T. on March 17.

Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a broad range of interventional medical specialties. For more information, please visit: www.bostonscientific.com.

    CONTACT: Paul Donovan
             508-650-8541 (office)
             508-667-5165 (mobile)
             Media Relations
             Boston Scientific Corporation

             Larry Neumann
             508-650-8696 (office)
             Investor Relations
             Boston Scientific Corporation


'/>"/>
SOURCE Boston Scientific Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Boston Micromachines Multi-DM Named One of the Years Most Innovative Products
2. Boston University School of Medicine researcher recipient of Memory Ride Grant
3. Success of Shape-Up Somerville Childhood Obesity Intervention to be Presented at the Friedman School Symposium at Tufts, October 29-31, 2007 - Boston
4. AAHFNs 2008 Annual Meeting in Boston Will Be Raising the Bar in Heart Failure Care
5. Families Invited to Celebrate Shire Day at Boston Childrens Museum
6. Boston Scientific Announces New Initiatives to Increase Shareholder Value
7. Boston Scientific Announces Additions to Clinical Sciences Organization
8. Boston University School of Medicine physician receives award from AATOD
9. Boston Scientific Announces Verdict in Cordis Litigation
10. Boston Scientific Announces Sale of Cardiac Surgery and Vascular Surgery Businesses
11. Boston Scientific and GE Healthcare Announce their First Patient Data Link to Electronic Medical Record
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2014)... Independent review is a critical component ... care along the continuum. Health plans, consumers and ... accredited independent review organizations (IROs) at multiple touch ... a core function, IROs provide objective, evidence-based physician ... necessity. Yet backed by expertise, they do much ...
(Date:9/2/2014)... (PRWEB) September 03, 2014 IMCA Speedway ... kick off on September 1, 2014 at the IMCA ... the pre-race ceremony will include a check presentation to ... The Warriors® is a national nonprofit organization that assists ... fallen who have sustained physical and psychological wounds in ...
(Date:9/2/2014)... pot might be risky business for women, according ... study is the first to demonstrate sex differences ... , Psychology professor Rebecca Craft showed that, thanks ... least 30 percent more sensitive than males to ... in cannabis. Females also develop tolerance to THC ...
(Date:9/2/2014)... countries with dog control policies have curbed an infectious ... lurk in the majority of dog populations around the ... is according to research published in the open access ... of veterinarians across the world confirmed that Canine Transmissible ... the University of Cambridge found that the countries and ...
(Date:9/2/2014)... FL (PRWEB) September 02, 2014 After respective performances ... compete against each other on September 5th at Sun Life Stadium. ... the brightest stars in the world of football in Colombian and ... some of the best talent in the world in early September. ... the world according to FIFA. The host nation of the ...
Breaking Medicine News(10 mins):Health News:Independent Review Expands Its Scope: Case Studies in Context 2Health News:Independent Review Expands Its Scope: Case Studies in Context 3Health News:IMCA to Present Donation to Hope For The Warriors 2Health News:Estrogen increases cannabis sensitivity 2Health News:Estrogen increases cannabis sensitivity 3Health News:Global snapshot of infectious canine cancer shows how to control the disease 2Health News:Brazil Vs. Colombia Tickets in Miami at Sun Life Stadium: Dazzling Deals Tickets Advises Soccer Fans To Reserve Tickets Early for Brazil vs. Colombia Rematch in Florida 2Health News:Brazil Vs. Colombia Tickets in Miami at Sun Life Stadium: Dazzling Deals Tickets Advises Soccer Fans To Reserve Tickets Early for Brazil vs. Colombia Rematch in Florida 3
... Endocrine Society will present Ronald S. Swerdloff, M.D., ... Institute at Harbor-UCLA Medical Center (LA BioMed), with ... June 15-18 in San Francisco. , The Endocrine ... the full range of disciplines associated with endocrinology, ...
... Elsevier, the world-leading publisher of scientific, technical and medical ... new series of 2-volume titles designed to fill an ... Radiology series has been developed to meet radiologists, need ... highly readable format to make that information easy to ...
... But their tech savvy helps them use online programs ... June 10 (HealthDay News) -- Insomnia among U.S. combat ... seen in patients with chronic insomnia, according to University ... post-deployment adjustment disorders to 14 insomnia patients and 14 ...
... harder to get needed medical care, report says , , TUESDAY, ... who had inadequate health insurance to cover their medical expenses ... to more than 25 million people. , Hardest hit were ... 200 percent above the federal poverty level or those with ...
... Inc. (NYSE: MYL ),announced today that it ... Pharma Ltd. (NATCO) for NATCO,s glatiramer acetate pre-filled,syringes, ... used to treat,multiple sclerosis. The agreement grants Mylan ... major markets in Europe, Australia, New,Zealand, Japan and ...
... Dad begins,to put a lot on his plate at work to ... works to keep the bacon off his plate., Here,s a ... over,2 to 1. It,s no secret that millions of men in ... number. High,cholesterol has been linked to a number of health problems ...
Cached Medicine News:Health News:LA BioMed investigator wins Distinguished Educator Award 2Health News:New 'Expert Radiology' series fills a gap among available clinical imaging references 2Health News:Combat Vets Display Severe Sleep Disorders 2Health News:25 Million Americans Are 'Underinsured' 2Health News:25 Million Americans Are 'Underinsured' 3Health News:25 Million Americans Are 'Underinsured' 4Health News:Mylan Inc., NATCO Pharma Ltd. To Collaborate on Worldwide Marketing and Distribution of Generic Copaxone(R) 2Health News:Take the Fat Out of Father's Day! 2
(Date:9/2/2014)... , Sept. 2, 2014 Reportlinker.com ... available in its catalogue: Acute Heart ... http://www.reportlinker.com/p0689743/Acute-Heart-Failure-Global-Clinical-Trials-Review-H2-2014.html Acute ... Summary GlobalData,s clinical trial report, ... 2014" provides data on the Acute Heart Failure ...
(Date:9/2/2014)... 2014    - Los ... agentes antitrombóticos no utilizados óptimamente para prevenir la ... presentaciones de GARFIELD-AF en el ESC CONGRESS 2014 ... resultados de pacientes en riesgo de sufrir apoplejía ... Los datos de casi 12.500 pacientes reclutados ...
(Date:9/2/2014)... , -- GARFIELD-AF ... into treatment and outcomes of patients at risk ... Data from nearly 12,500 patients enrolled ... Fibrillation (GARFIELD-AF), an innovative, independent academic research initiative, ... fibrillation (AF) patients remain sub-optimal despite the transition ...
Breaking Medicine Technology:Acute Heart Failure Global Clinical Trials Review, H2, 2014 2Acute Heart Failure Global Clinical Trials Review, H2, 2014 3Acute Heart Failure Global Clinical Trials Review, H2, 2014 4Acute Heart Failure Global Clinical Trials Review, H2, 2014 5Acute Heart Failure Global Clinical Trials Review, H2, 2014 6Acute Heart Failure Global Clinical Trials Review, H2, 2014 7Acute Heart Failure Global Clinical Trials Review, H2, 2014 8Los datos sobre fibrilación atrial muestran agentes antitrombóticos no usados óptimamente para prevenir la apoplejía 2Los datos sobre fibrilación atrial muestran agentes antitrombóticos no usados óptimamente para prevenir la apoplejía 3Los datos sobre fibrilación atrial muestran agentes antitrombóticos no usados óptimamente para prevenir la apoplejía 4Los datos sobre fibrilación atrial muestran agentes antitrombóticos no usados óptimamente para prevenir la apoplejía 5Los datos sobre fibrilación atrial muestran agentes antitrombóticos no usados óptimamente para prevenir la apoplejía 6Los datos sobre fibrilación atrial muestran agentes antitrombóticos no usados óptimamente para prevenir la apoplejía 7Los datos sobre fibrilación atrial muestran agentes antitrombóticos no usados óptimamente para prevenir la apoplejía 8Los datos sobre fibrilación atrial muestran agentes antitrombóticos no usados óptimamente para prevenir la apoplejía 9Los datos sobre fibrilación atrial muestran agentes antitrombóticos no usados óptimamente para prevenir la apoplejía 10Los datos sobre fibrilación atrial muestran agentes antitrombóticos no usados óptimamente para prevenir la apoplejía 11Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 2Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 3Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 4Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 5Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 6Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 7Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 8Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 9
... HORSHAM, Pa. , July 28 Teva Respiratory ... efficacy and safety of beclomethasone dipropionate (BDP) hydrofluoroalkane (HFA) Nasal Aerosol ... all efficacy endpoints, demonstrating a statistically significant benefit as compared to ... similar to placebo. , , ...
... BOCA RATON, Fla. , July 28 ... Pharma, the company will market Methylphenidate Solution, the generic ... an Abbreviated New Drug Application (ANDA).  Under the terms ... Tris Pharma, and marketed and distributed by Breckenridge on ...
Cached Medicine Technology:Teva Respiratory Announces Positive Results From Phase III Trial of BDP HFA Nasal Aerosol in Seasonal Allergic Rhinitis 2Teva Respiratory Announces Positive Results From Phase III Trial of BDP HFA Nasal Aerosol in Seasonal Allergic Rhinitis 3Teva Respiratory Announces Positive Results From Phase III Trial of BDP HFA Nasal Aerosol in Seasonal Allergic Rhinitis 4Teva Respiratory Announces Positive Results From Phase III Trial of BDP HFA Nasal Aerosol in Seasonal Allergic Rhinitis 5Teva Respiratory Announces Positive Results From Phase III Trial of BDP HFA Nasal Aerosol in Seasonal Allergic Rhinitis 6Breckenridge Pharmaceutical to Market Methylphenidate Oral Solution Through Agreement With Tris Pharma (Monmouth Junction, NJ) 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: